The University of Oklahoma Health Sciences Center and the NCI-Designated Stephenson Cancer Center are proud to host the 2018 END2CANCER: Emerging Nanotechnology and Drug Delivery Applications for Cancer conference from December 6-7, 2018 in Oklahoma City, Oklahoma, USA.
The END2CANCER conference will start the morning of December 6th, 2018 and conclude in the afternoon of December 7th, 2018. The conference will bridge laboratory research conducted in the areas of nanotechnology and drug delivery to clinical application for the detection, diagnosis, imaging and treatment of cancer. The conference will host keynote, plenary and invited lectures by eminent scientists who will discuss new and emerging concepts, technologies and challenges in translating nanomedicine from bench-to-bedside.
Date: December 6-7, 2018
Samis Education Center
1200 Children's Ave,
Oklahoma City, OK 73104
For more information, please visit end2cancer.com